Literature DB >> 32513647

Recurrent vulvovaginal candidiasis.

Annabel Lines1, Inna Vardi-Flynn2, Clare Searle3.   

Abstract

Entities:  

Year:  2020        PMID： 32513647     DOI： 10.1136/bmj.m1995

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  α-galactosylceramide-stimulated invariant natural killer T-cells play a protective role in murine vulvovaginal candidiasis by Candida albicans.

Authors:  Masahiro Abe; Yuki Kinjo; Sota Sadamoto; Minoru Shinozaki; Minoru Nagi; Kazutoshi Shibuya; Yoshitsugu Miyazaki
Journal:  PLoS One       Date:  2021-11-16       Impact factor: 3.240

2.  Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis.

Authors:  Gai Ge; Zhiya Yang; Dongmei Li; Ning Zhang; Biao Chen; Dongmei Shi
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

3.  Lived experience of medical management in recurrent vulvovaginal candidiasis: a qualitative study of an uncertain journey.

Authors:  Moira Bradfield Strydom; Ramesh L Walpola; Sara McMillan; Sohil Khan; Robert S Ware; Evelin Tiralongo
Journal:  BMC Womens Health       Date:  2022-09-19       Impact factor: 2.742

Review 4.  Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion.

Authors:  Gilbert Donders; István Oszkár Sziller; Jorma Paavonen; Phillip Hay; Francesco de Seta; Jean Marc Bohbot; Jan Kotarski; Jordi Antoni Vives; Bela Szabo; Ramona Cepuliené; Werner Mendling
Journal:  Front Cell Infect Microbiol       Date:  2022-09-09       Impact factor: 6.073
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.